BRIEF-Elate Group Inc Files To Withdraw IPO Plans - SEC Filing-February 2024-www.financetom.com

BRIEF-Elate Group Inc Files To Withdraw IPO Plans - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Elate Group Inc Files To Withdraw IPO Plans - SEC Filing

Mar 8, 2024 3:34 AM

March 8 (Reuters) - Elate Group Inc:

* ELATE GROUP INC FILES TO WITHDRAW IPO PLANS - SEC FILING

* ELATE GROUP INC SAYS HAD PREVIOUSLY FILED FOR IPO ON APRIL

2022

Source text for Eikon:

Further company coverage:

Previous page： Adobe Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Fiscal Q1 Outlook Set; Shares Fall Next page： Meridianlink Insider Sold Shares Worth $284,301, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Adobe Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Fiscal Q1 Outlook Set; Shares Fall

Dec 11, 2024

04:17 PM EST, 12/11/2024 (MT Newswires) -- Adobe (ADBE) reported fiscal Q4 non-GAAP earnings late Wednesday of $4.81 per diluted share, up from $4.27 a year earlier. Analysts polled by FactSet expected $4.67. Revenue in the three months ended Nov. 30 rose to $5.61 billion from $5.05 billion a year earlier. Analysts surveyed by FactSet expected $5.54 billion. The company...

Meridianlink Insider Sold Shares Worth $284,301, According to a Recent SEC Filing

Dec 11, 2024

04:16 PM EST, 12/11/2024 (MT Newswires) -- Timothy Nguyen, 10% Owner, on December 09, 2024, sold 12,347 shares in Meridianlink ( MLNK ) for $284,301. Following the Form 4 filing with the SEC, Nguyen has control over a total of 11,426,971 shares of the company, with 11,426,971 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1834494/000183449424000177/xslF345X05/wk-form4_1733951636.xml ...

Corcept Therapeutics' ALS drug fails in mid-stage trial

Dec 11, 2024

Dec 11 (Reuters) - Corcept Therapeutics ( CORT ) said on Wednesday its experimental drug failed to meet the main goal of a mid-stage trial in patients with amyotrophic lateral sclerosis, a fatal neurodegenerative disease. ...

Intapp Insider Sold Shares Worth $1,359,357, According to a Recent SEC Filing

Dec 11, 2024

04:17 PM EST, 12/11/2024 (MT Newswires) -- Thad Jampol, Chief Product Officer, on December 09, 2024, sold 20,000 shares in Intapp ( INTA ) for $1,359,357. Following the Form 4 filing with the SEC, Jampol has control over a total of 863,250 shares of the company, with 798,222 shares held directly and 65,028 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1565687/000112760224029136/xslF345X05/form4.xml ...